Kvika Asset Management

PLAIO is an AI-powered planning platform specifically designed for the pharmaceutical industry, aimed at transforming supply chain and operational management. The platform replaces traditional spreadsheet-based planning with advanced AI, machine learning, and real-time data analytics, optimizing demand, manufacturing, and purchasing processes. It integrates seamlessly with existing ERP systems, enhancing data-driven decision-making and improving forecast accuracy while streamlining planning workflows. Tailored for small to medium-sized pharmaceutical manufacturers and virtual pharma companies, PLAIO helps clients mitigate risks, reduce costs, and increase efficiency in a highly regulated and competitive landscape. The platform features capabilities such as visual and capacity planning, advanced constraint calculations, what-if analysis, AI-based automation, and scalability, enabling agile manufacturing operations and precise product output.

EpiEndo Pharmaceuticals is a clinical-stage biopharmaceutical company focused on inflammatory disorders by strengthening epithelial barrier integrity, a key factor in the progression of diseases affecting the skin, lungs, intestinal tract, and genital tract. It develops proprietary, orally available macrolide drug candidates with potential as first-in-class, disease-modifying therapies for chronic respiratory diseases and other significant unmet medical needs. Its lead candidate, EP395, aims to be the first oral, non-antibiotic macrolide that reinforces barrier function and provides anti-inflammatory effects for COPD and related inflammatory airway conditions.